Clinical Trial Update: Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating chemotherapy given concurrently with treatment guided by genetic testing in patients with high-risk salivary gland tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Salivary Gland Tumors

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Salivary Gland Tumors, Head and Neck Cancer | Phase 1 | Status: COMPLETED